Drummer O H, Kourtis S, Johnson H
University of Melbourne, Department of Medicine, Austin Hospital, Heidelberg, Australia.
Biochem Pharmacol. 1990 Feb 1;39(3):513-8. doi: 10.1016/0006-2952(90)90058-s.
We have investigated the effect of chronic administration of enalapril on the carboxypeptidases responsible for the formation of angiotensin II from angiotensin I and other peptidases known to recognize angiotensin I as a substrate in the rat. These studies have shown an increase in activity in rate of formation of des-Leu-angiotensin I in both kidney S2 and P2 centrifugal fractions as well as a decrease in the rate of degradation of angiotensin I substrate. Similar increases in the formation of A(1-8) have been observed in kidney using A(1-9) as substrate. These two enzyme activities have been named carboxypeptidase K1 and K2, respectively to reflect their presence in rat kidney. These changes were accompanied by significant decreases in the activity of an amastatin-sensitive aminopeptidase and endopeptidase 24.11 in the kidney P2 fraction. These data suggest that chronic treatment with ACE inhibitors may differentially affect the activity of other enzymes capable of degrading angiotensin causing a substantial re-direction of angiotensin metabolism.
我们研究了长期给予依那普利对大鼠体内负责将血管紧张素I转化为血管紧张素II的羧肽酶以及其他已知将血管紧张素I作为底物的肽酶的影响。这些研究表明,在肾脏S2和P2离心组分中,去亮氨酸血管紧张素I的生成速率增加,同时血管紧张素I底物的降解速率降低。在肾脏中以A(1-9)为底物时,也观察到了类似的A(1-8)生成增加。这两种酶活性分别被命名为羧肽酶K1和K2,以反映它们在大鼠肾脏中的存在。这些变化伴随着肾脏P2组分中氨肽酶抑制剂敏感的氨肽酶和内肽酶24.11活性的显著降低。这些数据表明,长期使用ACE抑制剂可能会对其他能够降解血管紧张素的酶的活性产生不同影响,从而导致血管紧张素代谢的显著重新定向。